Switch to:

Intercept Pharmaceuticals Inc (ICPT) Ownership Data

Short Interest History (%)

This is the historical short interest of Intercept Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest (%)Short Interest (Shares in Mil)
May 31, 201748.345.60
May 15, 201748.675.64
April 28, 201747.785.54
April 13, 201756.35.53
March 31, 201756.965.60
March 15, 201759.395.83
February 28, 201757.715.67
February 15, 201758.885.78
January 31, 201755.235.43
January 13, 201753.755.28
December 30, 201649.784.89
December 15, 201646.834.60
November 30, 201649.764.89
November 15, 201648.084.72
October 31, 201646.384.56
October 14, 201643.594.28
September 30, 201642.034.13
September 15, 201641.814.11
August 31, 201643.94.31
August 15, 201642.654.19
July 29, 201644.394.36
July 15, 201645.684.49
June 30, 201640.623.99
June 15, 201639.663.90
May 31, 201633.813.32
May 13, 201634.663.40
April 29, 201635.543.49
April 15, 201634.363.37
March 31, 201627.953.61
March 15, 201629.643.83
February 29, 201629.163.77
February 12, 201629.943.87
January 29, 201626.283.39
January 15, 201625.063.24
December 31, 201524.023.10
December 15, 201520.982.71
November 30, 201521.532.78
November 13, 201520.582.66
October 30, 201519.12.47
October 15, 201519.872.57
September 30, 201521.132.69
September 15, 201520.132.57
August 31, 201519.132.44
August 14, 201518.772.39
July 31, 201518.462.35
July 15, 201519.742.52
June 30, 201521.442.73
June 15, 201521.462.73
May 29, 201522.392.85
May 15, 201520.62.62
April 30, 201520.052.56
April 15, 201519.632.50
March 31, 201526.612.62
March 13, 201528.122.77
February 27, 201527.852.75
February 13, 201527.32.69
January 30, 201529.52.91
January 15, 201529.592.92
December 31, 201427.282.69
December 15, 201424.042.37
November 28, 201421.932.16
November 14, 201421.722.14
October 31, 201415.351.51
October 15, 201410.311.02
September 30, 20149.20.91
September 15, 20147.750.76
August 29, 20146.340.63
August 15, 20146.050.60
July 31, 20148.070.80
July 15, 20147.210.71
June 30, 20148.180.81
June 13, 20149.710.96
May 30, 20149.80.97
May 15, 20147.570.74
April 30, 20145.650.55
April 15, 20144.250.42
March 31, 20146.070.38
March 14, 20149.480.59
February 28, 20149.520.59
February 14, 201410.440.65
January 31, 20149.410.58
January 15, 20148.950.56
December 31, 201313.320.83
December 13, 20138.640.54
November 29, 20138.360.52
November 15, 20135.580.35
October 31, 20134.640.29
October 15, 20135.250.33
September 30, 20133.520.22
September 13, 20133.680.23
August 30, 20133.470.22
August 15, 20133.170.20
July 31, 20133.150.20
July 15, 20133.670.23
June 28, 20132.850.18
June 14, 20132.760.17
May 31, 20132.80.17
May 15, 20133.030.19
April 30, 20133.460.22
April 15, 20133.540.22
March 28, 20133.890.20
March 15, 20133.740.19
February 28, 20133.70.19
February 15, 20133.30.17
January 31, 20132.470.13
January 15, 20132.760.14
December 31, 20123.370.17
December 14, 20120.270.01
November 30, 20120.130.01
November 15, 20120.160.01
October 31, 20120.050.00

Institutional Ownership History (%)

This the Institutional Ownership History of Intercept Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership (%)Institutional Ownership (Shares in Mil)
March 31, 201784.5921.16
December 31, 201685.6421.25
September 30, 201685.3221.16
June 30, 201685.3821.05
March 31, 201679.3319.52
December 31, 201577.4918.90
September 30, 201583.4718.53
June 30, 201576.1418.39
March 31, 201579.6918.08
September 30, 201461.213.05
June 30, 201470.6814.97
March 31, 201463.5612.44
December 31, 201392.8218.00
September 30, 201361.411.85
June 30, 201347.058.96
March 31, 201339.476.57
December 31, 201236.4413.21

Insider ownership (%)

This is the historical insider ownership of Intercept Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership (%)Insider Ownership (Shares in Mil)
May 31, 20173.160.79
April 30, 20173.160.78
March 31, 20173.170.79
February 28, 20173.120.77
January 31, 20172.940.73
December 31, 20162.970.73
November 30, 20162.960.73
October 31, 20162.960.73
September 30, 20162.980.74
August 31, 20162.980.74
July 31, 20162.930.72
June 30, 20162.870.71
May 31, 20162.870.71
April 30, 20162.890.71
March 31, 20162.90.71
February 29, 20162.910.71
January 31, 20162.710.66
December 31, 20152.90.71
November 30, 20152.650.64
October 31, 20152.640.64
September 30, 20152.640.64
August 31, 20152.440.59
July 31, 20152.450.59
June 30, 20152.450.59
May 31, 20152.420.59
April 30, 20152.410.58
March 31, 20152.530.57
February 28, 20152.530.57
January 31, 20152.630.56
December 31, 20142.130.45
November 30, 20142.610.55
October 31, 20142.560.54
September 30, 20142.560.54
August 31, 20142.530.54
July 31, 20142.550.54
June 30, 20142.550.54
May 31, 20142.520.53

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Mark Pruzanski, M.D.CEO & President572,9052.29%2016-12-31
Mr. David Shapiro, M.D.CMO and EVP - Development46,3690.19%2017-03-01
Ms. Barbara G. DuncanChief Accounting Officer30,6610.12%2016-10-03
Ms. Lisa BrightPresident International23,314less than 0.1%2017-03-02
Mr. Sandip S. KapadiaN/A22,000less than 0.1%2017-02-01
Rachel McMinnChief Strategy Officer17,916less than 0.1%2017-02-01
Mr. Jerome B. DursoN/A15,000less than 0.1%2017-02-23
Dr. Srinivas Akkaraju,M.D.N/A13,246less than 0.1%2016-07-19
Dr. Luciano Adorini, M.D.N/A12,608less than 0.1%2015-10-01
Mr. Paolo FundaroN/A10,075less than 0.1%2016-07-19

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
State Street Corp   Premium Plus751,0272016-12-313.030.0181,600
Orbimed Advisors, LLC   Premium Plus1,120,0002016-12-314.511.55121,688
Capital World Investors   Premium Plus2,142,4592016-12-318.630.06232,778
Citadel Advisors Llc   Premium Plus426,5052016-09-301.720.0770,198
Carmignac Gestion   Premium Plus2,022,7922016-12-318.151.71219,776
Vanguard Group Inc   Premium Plus1,214,0322016-12-314.890.01131,905
BlackRock Fund Advisors   Premium Plus493,6702016-09-301.990.0281,253
J.P. Morgan Investment Management Inc   Premium Plus659,2082016-12-312.660.0371,623
Fidelity Management and Research Company   Premium Plus3,721,3162016-12-3015.00N/A376,299
Columbia Mangmt Investment Advisers, LLC   Premium Plus2,499,0582016-12-3110.070.19271,523
Highfields Capital Management LP   Premium Plus464,2322016-12-311.870.4250,439
Hansard EU Carmignac Patrimoine1,323,1922016-06-305.360.70188,793
Fidelity® Select Biotechnology Portfolio1,112,7682017-01-314.481.38122,126
Columbia Select Large Cap Growth Fund1,033,8942017-01-314.162.62113,470
VA CollegeAmerica Growth Fund of America812,7002016-12-313.270.0688,300
VA CollegeAmerica American Balanced706,6222016-12-312.850.0876,774
SPDR® S&P Biotech ETF580,1932017-03-072.232.3670,598
Hansard EU Carmignac Investissement549,7292016-06-302.231.4178,435
Vanguard Small Cap Index366,4472017-01-311.480.0640,218
American Funds NVIT Growth360,0002016-12-311.450.1939,114

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK